Androgen signaling regulates SARS-CoV-2 receptor levels and is associated with severe COVID-19 symptoms in men RM Samuel, H Majd, MN Richter, Z Ghazizadeh, SM Zekavat, A Navickas, ... Cell Stem Cell 27 (6), 876-889. e12, 2020 | 239 | 2020 |
The Surface Rhamnopolysaccharide Epa of Enterococcus faecalis Is a Key Determinant of Intestinal Colonization L Rigottier-Gois, C Madec, A Navickas, RC Matos, E Akary-Lepage, ... The Journal of Infectious Diseases 211 (1), 62-71, 2015 | 74 | 2015 |
Nuclear TARBP2 drives oncogenic dysregulation of RNA splicing and decay L Fish, A Navickas, B Culbertson, Y Xu, HCB Nguyen, S Zhang, ... Molecular cell 75 (5), 967-981. e9, 2019 | 66 | 2019 |
Neuronal Nsun2 deficiency produces tRNA epitranscriptomic alterations and proteomic shifts impacting synaptic signaling and behavior J Blaze, A Navickas, HL Phillips, S Heissel, A Plaza-Jennings, S Miglani, ... Nature communications 12 (1), 4913, 2021 | 59 | 2021 |
A prometastatic splicing program regulated by SNRPA1 interactions with structured RNA elements L Fish, M Khoroshkin, A Navickas, K Garcia, B Culbertson, B Hänisch, ... Science 372 (6543), eabc7531, 2021 | 49 | 2021 |
No-Go Decay mRNA cleavage in the ribosome exit tunnel produces 5′-OH ends phosphorylated by Trl1 A Navickas, S Chamois, R Saint-Fort, J Henri, C Torchet, L Benard Nature communications 11 (1), 122, 2020 | 41 | 2020 |
RBMS1 suppresses colon cancer metastasis through targeted stabilization of its mRNA regulon J Yu, A Navickas, H Asgharian, B Culbertson, L Fish, K Garcia, ... Cancer discovery 10 (9), 1410-1423, 2020 | 40 | 2020 |
Cytoplasmic control of sense-antisense mRNA pairs F Sinturel, A Navickas, M Wery, M Descrimes, A Morillon, C Torchet, ... Cell reports 12 (11), 1853-1864, 2015 | 33 | 2015 |
An mRNA processing pathway suppresses metastasis by governing translational control from the nucleus A Navickas, H Asgharian, J Winkler, L Fish, K Garcia, D Markett, M Dodel, ... Nature cell biology 25 (6), 892-903, 2023 | 16 | 2023 |
A sense-antisense RNA interaction promotes breast cancer metastasis via regulation of NQO1 expression B Culbertson, K Garcia, D Markett, H Asgharian, L Chen, L Fish, ... Nature cancer 4 (5), 682-698, 2023 | 14 | 2023 |
A bi-steric mTORC1-selective inhibitor overcomes drug resistance in breast cancer D Meng, X Zhao, YC Yang, A Navickas, C Helland, H Goodarzi, M Singh, ... Oncogene 42 (28), 2207-2217, 2023 | 5 | 2023 |
A unique No-Go decay cleavage in mRNA exit-tunnel of ribosome produces 5’-OH ends phosphorylated by Rlg1 A Navickas, S Chamois, R Saint-Fort, J Henri, C Torchet, L Benard Biorxiv, 465633, 2018 | 5 | 2018 |
A systematic search for RNA structural switches across the human transcriptome M Khoroshkin, D Asarnow, S Zhou, A Navickas, A Winters, J Goudreau, ... Nature Methods, 1-12, 2024 | 4 | 2024 |
Translational adaptation in breast cancer metastasis and emerging therapeutic opportunities S Chen, A Navickas, H Goodarzi Trends in Pharmacological Sciences, 2024 | 2 | 2024 |
Generation of Schwann cell derived melanocytes from hPSCs identifies pro-metastatic factors in melanoma RM Samuel, A Navickas, A Maynard, EA Gaylord, K Garcia, S Bhat, ... BioRxiv, 2023 | 2 | 2023 |
Revealing the grammar of small RNA secretion using interpretable machine learning B Zirak, M Naghipourfar, A Saberi, D Pouyabahar, A Zarezadeh, L Luo, ... Cell Genomics 4 (4), 2024 | 1 | 2024 |
Integrative identification of non-coding regulatory regions driving metastatic prostate cancer BJ Woo, R Moussavi-Baygi, H Karner, M Karimzadeh, K Garcia, T Joshi, ... bioRxiv, 2023 | 1 | 2023 |
A multiomics approach reveals RNA dynamics promote cellular sensitivity to DNA hypomethylation AY Ge, A Arab, R Dai, A Navickas, L Fish, K Garcia, H Asgharian, ... bioRxiv, 2022.12. 14.518457, 2022 | 1 | 2022 |
Rekombinantinė teleologija kaip repetityvinio komponavimo paradigma A Navickas Magistro mokslo darbas. Vadovė Rūta Stanevičiūtė. Vilnius: LMTA, 2009 | 1 | 2009 |
Post-transcriptional gene regulation: From mechanisms to RNA chemistry and therapeutics C Bonnet, AL Dian, T Espie-Caullet, L Fabbri, L Lagadec, T Pivron, ... Bulletin du Cancer 111 (7-8), 782-790, 2024 | | 2024 |